Welcome to Bayer Schering Pharma’s “From Targets To Novel Drugs” initiative
Our company’s mission is to provide new treatment options for diseases with high unmet medical need. We are committed to innovation and to translating ideas from basic research into novel drugs.
We are dedicated to fostering collaborations with excellent academic groups and start-ups. In order to further pool expertise and to join forces for mutual benefit, Bayer Schering Pharma AG intends to support collaborative research projects on attractive, novel molecular targets in the fields of To promote this new approach, Bayer Schering Pharma AG intends to allocate grants for the further development of promising targets. We look forward to hearing about your innovative ideas! On the following pages you will find more information on this initiative and the submission process.
The next submission deadline is January 31, 2010.
We are dedicated to fostering collaborations with excellent academic groups and start-ups. In order to further pool expertise and to join forces for mutual benefit, Bayer Schering Pharma AG intends to support collaborative research projects on attractive, novel molecular targets in the fields of To promote this new approach, Bayer Schering Pharma AG intends to allocate grants for the further development of promising targets. We look forward to hearing about your innovative ideas! On the following pages you will find more information on this initiative and the submission process.
The next submission deadline is January 31, 2010.